Showing results (301-310 of 566) with videos related to

Sort By:
Pageof 57
Rheumatology (Oxford, England)|June 27, 2018
Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)Alice B Gottlieb, Vibeke Strand, Mitsumasa Kishimoto, et al.
Arthritis and Rheumatism|November 1, 2008
Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group studyEdward Keystone, Désireé van der Heijde, David Mason, et al.
Rheumatology and Therapy|May 16, 2026
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials)Roy M Fleischmann, Vibeke Strand, Eugen Feist, et al.
Rheumatology and Therapy|October 12, 2021
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1Vibeke Strand, Philip J Mease, Enrique R Soriano, et al.
The Journal of Rheumatology|August 4, 2005
Use of combination of leflunomide with biological agents in treatment of rheumatoid arthritisJoachim R Kalden, Christian Antoni, Jose M Alvaro-Gracia, et al.
The Journal of Rheumatology|September 3, 2011
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experienceCharles G Peterfy, Peter Countryman, Annarita Gabriele, et al.
The Lancet. Rheumatology|January 30, 2024
The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trialVibeke Strand, Gurjit S Kaeley, Martin J Bergman, et al.
Clinical and Experimental Rheumatology|December 7, 2021
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with ageChristof Specker, Martin Aringer, Gerd-Rüdiger Burmester, et al.
Arthritis and Rheumatism|October 2, 2007
Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusTanja A Stamm, Bettina Bauernfeind, Michaela Coenen, et al.
Rheumatology (Oxford, England)|December 14, 2020
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPYVibeke Strand, Namita Tundia, Alvin Wells, et al.
Pageof 57